If the drugs are directly both improving weight reduction and cancer reduction, then we need to double down. Ganta wonders the same thing about the drugs apparent positive effects on several conditions, from dementia to sleep apnea: Is it that obesity is causing or contributing to the problem [and that weight loss is causing the improvement], or is the medication directly having an impact through a different mechanism? She hopes there will be more research to parse this out in the years to come
Some patients describe a persistent metallic taste, particularly noticeable when eating or drinking, or report that familiar foods taste "off" or different from usual
Direct Stimulation of GLP-1 Receptors in the Brain: GLP-1 receptors are found in various areas of the brain, particularly those involved in appetite control and the sensation of nausea
The tolerability advantage over Semaglutide, combined with superior efficacy, makes the side effect-to-benefit ratio particularly favourable for Retatrutide
3. Improved Insulin Sensitivity
2.4% placebo) 86% of participants lost at least 5% 69% lost at least 10% 50% lost at least 15% 32% lost at least 20% What this means practically: For someone weighing 220 pounds: Average result: 33 pounds lost (reaching 187 pounds) Good responder: 44 pounds lost (reaching 176 pounds) Excellent responder: 55+ pounds lost (reaching 165 pounds or lower) For detailed results, see our guide on Ozempic weight loss results
